Novel disulfidptosis‐derived gene blueprint stratifying patients with breast cancer
Environmental Toxicology · 2024
DOI: 10.1002/tox.24043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Xiaojiang Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Introduction
Breast cancer remains the predominant cancer among females, accounting for about 24.2% of all cancer cases. Alarmingly, it is the primary cause of cancer‐related mortality in women under 45.
Methods
This research analyzed RNA sequencing data from 1082 TCGA‐BRCA and 107 GSE58812 breast cancer patients. Single‐cell RNA data from five patients in the GSE118389 data set were also studied. Using Random forest and COX regression, we developed a prognostic model. Pathway analysis employed GSVA and GO, while immune profiles were assessed via ssGSEA and MCPcounter. Mutation patterns utilized maftools, and drug sensitivity scores were derived from the GDSC database with oncoPredict.
Results
Analysis of the GSE118389 data set identified three distinct cell types: immune, epithelial, and stromal. P53 and VEGF were notably enriched. Five key genes (TMEM251, ADAMTSL2, CDC123, PSMD1, TLE1) were pinpointed for their prognostic significance. We introduced a disulfidptosis‐associated score as a novel risk factor for breast cancer prognosis. Survival outcomes varied significantly between training and validation sets. Comprehensive immune profiling revealed no difference in activated CD8‐positive T cells between risk groups, but a positive correlation of NK cells, neutrophils, cytotoxic lymphocytes, and monocytic cells with the riskscore was noted. Importantly, a negative association between the drug Nelarabine and riskscore was identified.
Conclusion
This research underscores the significance of a disulfidptosis‐associated gene signature in breast cancer prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Division of Infection Control Management, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Xiaojiang Tang
Zitieren
APA
Tang, X., Ping, B., Liu, Y., & Zhou, Y. (2024). Novel disulfidptosis‐derived gene blueprint stratifying patients with breast cancer. Environmental Toxicology. https://doi.org/10.1002/tox.24043
Vancouver
Tang X, Ping B, Liu Y, Zhou Y. Novel disulfidptosis‐derived gene blueprint stratifying patients with breast cancer. Environmental Toxicology. 2024. doi:10.1002/tox.24043
BibTeX
@article{Tang2024,
author = {Tang, Xiaojiang and Ping, Baohua and Liu, Yang and Zhou, Yuhui},
title = {Novel disulfidptosis‐derived gene blueprint stratifying patients with breast cancer},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24043}
}
EUVIMED